PubRank

Keiichi Mitsuyama

Author PubWeight™ 48.03‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 2006 3.01
2 Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model. J Immunol 2009 1.62
3 Germinated barley foodstuff, a prebiotic product, ameliorates inflammation of colitis through modulation of the enteric environment. J Gastroenterol 2003 1.51
4 Altered expression of glucagon-like peptide-1 and dipeptidyl peptidase IV in patients with HCV-related glucose intolerance. J Gastroenterol Hepatol 2007 1.47
5 Suppression of interleukin-1beta- and tumor necrosis factor-alpha-induced inflammatory responses by leukocytapheresis therapy in patients with ulcerative colitis. J Gastroenterol 2004 1.46
6 Prebiotic treatment in experimental colitis reduces the risk of colitic cancer. J Gastroenterol Hepatol 2011 1.43
7 Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial. J Gastroenterol 2002 1.30
8 Interleukin-6 trans-signaling and colonic cancer associated with inflammatory bowel disease. Curr Pharm Des 2009 1.12
9 Interleukin-5 participates in the pathogenesis of ileitis in SAMP1/Yit mice. Eur J Immunol 2004 1.09
10 Terminal restriction fragment length polymorphism analysis of the diversity of fecal microbiota in patients with ulcerative colitis. Inflamm Bowel Dis 2007 1.09
11 Germinated barley foodstuff prolongs remission in patients with ulcerative colitis. Int J Mol Med 2004 1.08
12 Modification of intestinal flora in the treatment of inflammatory bowel disease. Curr Pharm Des 2003 1.00
13 Sub-classification of type VI pit patterns in colorectal tumors: relation to the depth of tumor invasion. Int J Oncol 2008 0.95
14 Treatment of ulcerative colitis patients by long-term administration of germinated barley foodstuff: multi-center open trial. Int J Mol Med 2003 0.95
15 Eubacterium limosum ameliorates experimental colitis and metabolite of microbe attenuates colonic inflammatory action with increase of mucosal integrity. World J Gastroenterol 2006 0.94
16 N-butyl-2-cyanoacrylate (histoacryl) glue in the right atrium after endoscopic injection for a ruptured duodenal varix: complication of histoacryl injection. Dig Endosc 2012 0.92
17 Lack of macrophage migration inhibitory factor suppresses innate immune response in murine dextran sulfate sodium-induced colitis. Scand J Gastroenterol 2008 0.91
18 Overview of the role of macrophage migration inhibitory factor (MIF) in inflammatory bowel disease. Curr Pharm Des 2009 0.91
19 New prebiotics from rice bran ameliorate inflammation in murine colitis models through the modulation of intestinal homeostasis and the mucosal immune system. Scand J Gastroenterol 2010 0.90
20 A new therapeutic approach using a schizophyllan-based drug delivery system for inflammatory bowel disease. Mol Ther 2012 0.89
21 Endoscopic discrimination of sessile serrated adenomas from other serrated lesions. Oncol Lett 2011 0.89
22 Endoscopic retrieval of migrated plastic stent into bile duct or pancreatic pseudocyst. Dig Endosc 2009 0.89
23 Clinical trial: Effects of an oral preparation of mesalazine at 4 g/day on moderately active ulcerative colitis. A phase III parallel-dosing study. J Gastroenterol 2010 0.89
24 Depletion of endothelial progenitor cells in the peripheral blood of patients with ulcerative colitis. Int J Mol Med 2007 0.88
25 Suppression of inflammatory cytokine secretion by granulocyte/monocyte adsorptive apheresis in active ulcerative colitis. Ther Apher Dial 2005 0.87
26 Prebiotic treatment of experimental colitis with germinated barley foodstuff: a comparison with probiotic or antibiotic treatment. Int J Mol Med 2002 0.85
27 Effects of the modulation of microbiota on the gastrointestinal immune system and bowel function. J Agric Food Chem 2013 0.83
28 Successful treatment of rectal ulcers in a patient with systemic lupus erythematosus using corticosteroids and tacrolimus. Mod Rheumatol 2014 0.83
29 Serum immunoglobulin G4 associated with number and distribution of extrapancreatic lesions in type 1 autoimmune pancreatitis patients. J Gastroenterol Hepatol 2012 0.82
30 Ratio of serum vascular endothelial growth factor to platelet count correlates with disease activity in a patient with POEMS syndrome. Eur J Intern Med 2002 0.82
31 Germinated barley foodstuff ameliorates inflammation in mice with colitis through modulation of mucosal immune system. Scand J Gastroenterol 2008 0.81
32 Leukocytapheresis Therapy Improved Cholestasis in a Patient Suffering from Primary Sclerosing Cholangitis with Ulcerative Colitis. Case Rep Gastroenterol 2009 0.81
33 The therapeutic impact of manipulating microbiota in inflammatory bowel disease. Curr Pharm Des 2009 0.80
34 Prebiotic treatment reduced preneoplastic lesions through the downregulation of toll like receptor 4 in a chemo-induced carcinogenic model. J Clin Biochem Nutr 2011 0.80
35 Microarray analyses of peripheral whole blood cells from ulcerative colitis patients: effects of leukocytapheresis. Int J Mol Med 2013 0.79
36 Leukocytapheresis for the treatment of active pouchitis: a pilot study. J Gastroenterol 2008 0.78
37 Preventive effects of enzyme-treated rice fiber in a restraint stress-induced irritable bowel syndrome model. Int J Mol Med 2010 0.78
38 A yeast extract high in bioactive peptides has a blood-pressure lowering effect in hypertensive model. Curr Med Chem 2005 0.78
39 Bifidogenic growth stimulator for the treatment of active ulcerative colitis: a pilot study. Nutrition 2005 0.77
40 A multicenter study of the efficacy and safety of leukocytapheresis therapy without concomitant systemic steroid treatment in patients with active ulcerative colitis. Transfus Apher Sci 2011 0.77
41 Efficacy of vascular endothelial growth factor in the treatment of experimental gastric injury. Digestion 2002 0.77
42 Modulation of intestinal environment by prebiotic germinated barley foodstuff prevents chemo-induced colonic carcinogenesis in rats. Oncol Rep 2008 0.77
43 Development of intrahepatic cholangiocarcinoma after a 14-year follow-up of a patient with primary sclerosing cholangitis and ulcerative colitis. Hepatol Res 2011 0.77
44 Leukocytapheresis therapy modulates circulating t cell subsets in patients with ulcerative colitis. Ther Apher Dial 2005 0.77
45 Roles of high-mobility group box 1 in murine experimental colitis. Mol Med Rep 2011 0.76
46 Modulation of platelet aggregation responses by leukocytapheresis therapy in patients with active ulcerative colitis. J Gastroenterol 2006 0.76
47 Balloon-occluded retrograde transvenous obliteration versus endoscopic injection sclerotherapy for isolated gastric varices: a comparative study. Kurume Med J 2014 0.76
48 Role of vascular endothelial growth factor in protein loss of Ménétrier's disease. Int J Mol Med 2006 0.76
49 Quantitative analysis of colorectal mucosal lesions by autofluorescence endoscopy: discrimination of carcinomas from other lesions. Oncol Rep 2011 0.75
50 Immunoregulatory cytokines and intestinal inflammation. J Gastroenterol 2005 0.75
51 Duodenal Metastases from Lung Carcinoma. Intern Med 2017 0.75
52 The new prophylactic strategy for colon cancer in inflammatory bowel disease by modulating microbiota. Scand J Gastroenterol 2012 0.75
53 Univariate analysis to examine predictors of response to leukocytapheresis in ulcerative colitis patients. Ther Apher Dial 2014 0.75
54 Long term results of balloon-occluded retrograde transvenous obliteration for portosystemic shunt encephalopathy in patients with liver cirrhosis and portal hypertension. Kurume Med J 2014 0.75
55 [A case of respiratory failure caused by pulmonary alveolar hemorrhage in Crohn's disease]. Nihon Shokakibyo Gakkai Zasshi 2004 0.75
56 Heating improves poor compliance with branched chain amino acid-rich supplementation in patients with liver cirrhosis: A before-after pilot study. Mol Med Rep 2011 0.75
57 Branched-chain amino acid supplements reduced ascites and increased the quality of life in a patient with liver cirrhosis: A case report. Mol Med Rep 2011 0.75
58 Mechanisms underlying the effects of leukocyte apheresis with a fiber filter in a rat model of dextran sulfate sodium-induced colitis. Dig Dis Sci 2009 0.75
59 Microarray analysis of leukocytapheresis-induced changes in gene expression patterns of peripheral blood mononuclear cells in patients with ulcerative colitis. Ther Apher Dial 2007 0.75
60 Editorial: The impact of microbiota and cytokines on inflammatory bowel disease. Curr Pharm Des 2009 0.75
61 [Total colon stricture in ulcerative colitis with various extrantestinal manifestations]. Nihon Shokakibyo Gakkai Zasshi 2002 0.75